MERCY STANLEY: Open Payments
NPI 1548511603 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,294 in 33 payments from 10 companies in 2025. Trend: 2023 $935 · 2024 $1,222 · 2025 $1,294
Food & beverage: $993Education: $301
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $531 |
| Syndax Pharmaceuticals, Inc. | 6 | $195 |
| SOBI, INC | 3 | $167 |
| Incyte Corporation | 4 | $114 |
| Lilly USA, LLC | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $66 |
| Celgene Corporation | 2 | $55 |
| ABBVIE INC. | 1 | $33 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: Xospata, Cresemba, JAKAFI, Doptelet, JAYPIRCA, Vonjo, CALQUENCE, REBLOZYL.
Industry payments across TX — which companies pay providers there.
